-
Loading metrics
Open Access
Peer-reviewed
Research Article
Effect of Cholecalciferol Supplementation on Inflammation and Cellular Alloimmunity in Hemodialysis Patients: Data from a Randomized Controlled Pilot Trial
-
Lily Li ,
Contributed equally to this work with: Lily Li, Marvin Lin
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Marvin Lin ,
Contributed equally to this work with: Lily Li, Marvin Lin
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Maria Krassilnikova,
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Katya Ostrow,
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Amanda Bader,
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Brian Radbill,
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Jaime Uribarri,
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Joji Tokita,
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Staci Leisman,
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Vijay Lapsia,
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Randy A. Albrecht,
Affiliations Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Adolfo García-Sastre,
Affiliations Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Andrea D. Branch,
Affiliations Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Peter S. Heeger ,
¶These authors are co-senior authors on this work.
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Recanati Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯ -
Anita Mehrotra
* E-mail: anita.mehrotra@mssm.edu
¶These authors are co-senior authors on this work.
Affiliations Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
⨯
Effect of Cholecalciferol Supplementation on Inflammation and Cellular Alloimmunity in Hemodialysis Patients: Data from a Randomized Controlled Pilot Trial
- Lily Li,
- Marvin Lin,
- Maria Krassilnikova,
- Katya Ostrow,
- Amanda Bader,
- Brian Radbill,
- Jaime Uribarri,
- Joji Tokita,
- Staci Leisman,
- Vijay Lapsia
- Published: October 8, 2014
- https://doi.org/10.1371/journal.pone.0109998